Reviewed,
UniProtKB/Swiss-Prot P01101 (FOS_MOUSE)
Last modified
November 3, 2009.
Version 84.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Proto-oncogene protein c-fos Alternative name(s): Cellular oncogene fos | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus |
Protein attributes
| Sequence length | 380 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Nuclear phosphoprotein which forms a tight but non-covalently linked complex with the JUN/AP-1 transcription factor. Has a critical function in regulating the development of cells destined to form and maintain the skeleton. It is thought to have an important role in signal transduction, cell proliferation and differentiation. Ref.5 Ref.6 Ref.7 |
| Subunit structure | Heterodimer. Interacts with DSIPI; this interaction inhibits the binding of active AP1 to its target DNA. Interacts with MAFB By similarity. |
| Subcellular location | |
| Post-translational modification | Phosphorylated in the C-terminal upon stimulation by nerve growth factor (NGF) and epidermal growth factor (EGF). Phosphorylated, in vitro, by MAPK and RSK1. Phosphorylation on both Ser-362 and Ser-374 by MAPK1/2 and RSK1/2 leads to protein stabilization with phosphorylation on Ser-374 being the major site for protein stabilization on NGF stimulation. Phosphorylation on Ser-362 and Ser-374 primes further phosphorylations on Thr-325 and Thr-331 through promoting docking of MAPK to the DEF domain. Phosphorylation on Thr-232, induced by HA-RAS, activates the transcriptional activity and antagonizes sumoylation. Phosphorylation on Ser-362 by RSK2 in osteoblasts contributes to osteoblast transformation By similarity. Constitutively sumoylated by SUMO1, SUMO2 and SUMO3. Desumoylated by SENP2. Sumoylation requires heterodimerization with JUN and is enhanced by mitogen stimulation. Sumoylation inhibits the AP-1 transcriptional activity and is, itself, inhibited by Ras-activated phosphorylation on Thr-232 By similarity. |
| Sequence similarities | Belongs to the bZIP family. Fos subfamily. Contains 1 bZIP domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Nucleus |
| Disease | Proto-oncogene |
| Ligand | DNA-binding |
| PTM | Isopeptide bond Phosphoprotein Ubl conjugation |
| Gene Ontology (GO) | |
| Biological process | cellular response to extracellular stimulus Inferred from mutant phenotype. Source: MGI nervous system developmentInferred from mutant phenotype. Source: MGI positive regulation of transcription from RNA polymerase II promoterInferred from mutant phenotype. Source: MGI response to drugInferred from direct assay. Source: MGI response to protein stimulusInferred from direct assay. Source: MGI |
| Cellular component | transcription factor complex Inferred from direct assay. Source: MGI |
| Molecular function | sequence-specific DNA binding Inferred from electronic annotation. Source: InterPro transcription factor activityInferred from direct assay. Source: MGI |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 380 | 380 | Proto-oncogene protein c-fos | PRO_0000076467 | |||||
Regions | |||||||||
| Domain | 165 – 193 | 29 | Leucine-zipper | ||||||
| DNA binding | 139 – 160 | 22 | Basic motif | ||||||
Amino acid modifications | |||||||||
| Modified residue | 232 | 1 | Phosphothreonine Ref.6 | ||||||
| Modified residue | 325 | 1 | Phosphothreonine Ref.5 Ref.6 | ||||||
| Modified residue | 331 | 1 | Phosphothreonine Ref.5 Ref.6 | ||||||
| Modified residue | 362 | 1 | Phosphoserine; by MAPK and RPS6KA3 Ref.5 Ref.6 Ref.7 | ||||||
| Modified residue | 374 | 1 | Phosphoserine; by MAPK Ref.5 Ref.6 | ||||||
| Cross-link | 113 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) By similarity | |||||||
| Cross-link | 265 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) By similarity | |||||||
Experimental info | |||||||||
| Mutagenesis | 232 | 1 | T → A: No effect on PDGF-stimulated enhancement of transcriptional activity. Completely abolishes PDGF-stimulated enhancement of transcriptional activity; when associated with A-325; A-331 and A-374. Ref.6 | ||||||
| Mutagenesis | 325 | 1 | T → A: Almost no EGF-mediated phosphorylation, greatly reduced cellular transformation, and reduced AP1 activity by 20%; when associated with A-331. No effect on PDGF-stimulated enhancement of transcriptional activity. Completely abolishes PDGF-stimulated enhancement of transcriptional activity; when associated with A-232; A-331 and A-374. Ref.5 Ref.6 | ||||||
| Mutagenesis | 331 | 1 | T → A: Almost no EGF-mediated phosphorylation, greatly reduced cellular transformation, and reduced AP1 activity by 20%; when associated with A-325. No effect on PDGF-stimulated enhancement of transcriptional activity. Completely abolishes PDGF-stimulated enhancement of transcriptional activity; when associated with A-232; A-325;and A-374. Ref.5 Ref.6 | ||||||
| Mutagenesis | 343 | 1 | F → A: Reduced phosphorylation by ERK. Reduced AP1 activity by 65%. Ref.5 | ||||||
| Mutagenesis | 345 | 1 | Y → A: Reduced phosphorylation by ERK. Ref.5 | ||||||
| Mutagenesis | 362 | 1 | S → D: Enhanced EGF- and RSK-mediated tranformation; when associated with D-374. Ref.5 | ||||||
| Mutagenesis | 362 | 1 | S → E: Increased enhancement of EGF- and RSK-mediated tranformation; when associated with E-374. Ref.5 | ||||||
| Mutagenesis | 374 | 1 | S → A: No effect on PDGF-stimulated enhancement of transcriptional activity. Completely abolishes PDGF-stimulated enhancement of transcriptional activity; when associated with A-232; A-325 and A-331. Ref.5 Ref.6 | ||||||
| Mutagenesis | 374 | 1 | S → D: Enhanced EGF- and RSK-mediated tranformation; when associated with D-362. Ref.5 Ref.6 | ||||||
| Mutagenesis | 374 | 1 | S → E: Increased enhanced EGF- and RSK-mediated tranformation; when associated with E-362. Ref.5 Ref.6 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini." van Beveren C., van Straaten F., Curran T., Mueller R., Verma I.M. Cell 32:1241-1255(1983) [PubMed: 6301687] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene." Meijlink F., Curran T., Miller A.D., Verma I.M. Proc. Natl. Acad. Sci. U.S.A. 82:4987-4991(1985) [PubMed: 2991903] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: FVB/N. Tissue: Mammary gland. |
| [4] | "Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ." Mittelstadt P.R., Ashwell J.D. J. Biol. Chem. 276:29603-29610(2001) [PubMed: 11397794] [Abstract] Cited for: INTERACTION WITH DSIPI. |
| [5] | "Molecular interpretation of ERK signal duration by immediate early gene products." Murphy L.O., Smith S., Chen R.H., Fingar D.C., Blenis J. Nat. Cell Biol. 4:556-564(2002) [PubMed: 12134156] [Abstract] Cited for: PHOSPHORYLATION AT THR-325; THR-331; SER-362 AND SER-374, FUNCTION, MUTAGENESIS OF THR-325; THR-331; PHE-343; TYR-345; SER-362 AND SER-374. |
| [6] | "Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor." Monje P., Marinissen M.J., Gutkind J.S. Mol. Cell. Biol. 23:7030-7043(2003) [PubMed: 12972619] [Abstract] Cited for: PHOSPHORYLATION AT THR-232; THR-325; THR-331; SER-362 AND SER-374, FUNCTION, MUTAGENESIS OF THR-232; THR-325; THR-331 AND SER-374. |
| [7] | "Essential role of RSK2 in c-Fos-dependent osteosarcoma development." David J.-P., Mehic D., Bakiri L., Schilling A.F., Mandic V., Priemel M., Idarraga M.H., Reschke M.O., Hoffmann O., Amling M., Wagner E.F. J. Clin. Invest. 115:664-672(2005) [PubMed: 15719069] [Abstract] Cited for: PHOSPHORYLATION AT SER-362, FUNCTION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| V00727 Genomic DNA. Translation: CAA24105.1. J00370 Genomic DNA. Translation: AAA96699.1. BC029814 mRNA. Translation: AAH29814.1. | |
| IPI | IPI00131985. |
| PIR | TVMSF. A01343. |
| RefSeq | NP_034364.1. |
| UniGene | Mm.246513 |
3D structure databases | |
| HSSP | HSSP built from PDB template 1FOS based on UniProtKB P01100. |
| SMR | P01101. Positions 139-198. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP:1066N. |
| STRING | P01101. |
PTM databases | |
| PhosphoSite | P01101. |
Proteomic databases | |
| PRIDE | P01101. |
Genome annotation databases | |
| Ensembl | ENSMUST00000021674; ENSMUSP00000021674; ENSMUSG00000021250; Mus musculus. [Genome view] |
| GeneID | 14281. |
| KEGG | mmu:14281. |
| UCSC | uc007oha.1. mouse. |
Organism-specific databases | |
| CTD | 14281. |
| MGI | MGI:95574. Fos. |
Phylogenomic databases | |
| HOGENOM | P01101. |
| HOVERGEN | P01101. |
| OMA | TYTSSFV. |
Gene expression databases | |
| ArrayExpress | P01101. |
| Bgee | P01101. |
| CleanEx | MM_FOS. |
| Genevestigator | P01101. |
| GermOnline | ENSMUSG00000021250. Mus musculus. |
Family and domain databases | |
| InterPro | IPR011616. bZIP_1. IPR000837. Leuzip_Fos. IPR004827. TF_bZIP. [Graphical view] |
| Pfam | PF00170. bZIP_1. 1 hit. [Graphical view] |
| PRINTS | PR00042. LEUZIPPRFOS. |
| SMART | SM00338. BRLZ. 1 hit. [Graphical view] |
| PROSITE | PS50217. BZIP. 1 hit. PS00036. BZIP_BASIC. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 285657. |
| SOURCE | Search... |
Entry information
| Entry name | FOS_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P01101 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


